United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$69Mraised across 3 rounds since 2015, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
F-Prime Capital
venBio PartnersReported by FinSMEsSEC filing: $11M sold, first sale Nov 2018
venBio PartnersReported by FinSMEsSEC filing: $27M sold, first sale Jun 2017
From a historical funding recordSEC filing: $10M sold, first sale Aug 2015
From the SEC filings it signed: 7 on the team.
On the board, as filediAlan FuhrmanCorey GoodmanKeith FlahertyMichael PowellPeter ColabuonoRobert Weisskoff
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
venBio PartnersF-Prime Capital
Sofinnova InvestmentsDecheng Capital/ SofinnovaF-Prime Capital Partners/ SofinnovaMissing a round, or an investor who was in one? Tell us.
This firm lists Checkmate Pharmaceuticals as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Checkmate Pharmaceuticals's investors include venBio Partners, F-Prime Capital, Sofinnova Investments, Decheng Capital/ Sofinnova and F-Prime Capital Partners/ Sofinnova.
Checkmate Pharmaceuticals has raised $69M across 3 rounds since 2015.
Checkmate Pharmaceuticals's most recent round was an Undisclosed round of $22M in Dec 2018.
Checkmate Pharmaceuticals's largest round on record is $27M (Series B), in Jun 2017.
Checkmate Pharmaceuticals's first round on record, in Aug 2015, was backed by Sofinnova Investments and venBio Partners.
Checkmate Pharmaceuticals's latest named round is an Undisclosed round, in Dec 2018.
Checkmate Pharmaceuticals is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
